The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
The two-century journey of Parkinson disease research
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Self-citationThe functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Primate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D.-F., Gautier, C. A., Shen, J., Cookson, M. R., & Youle, R. J. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000298 · Cited by 2,944
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
Ungerstedt, U., & Arbuthnott, G. W. (1970) · Brain Research · doi:10.1016/0006-8993(70)90187-3 · Cited by 1,978
Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
Bergman, H., Wichmann, T., & DeLong, M. R. (1990) · Science · doi:10.1126/science.2402638 · Cited by 1,907
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry
Kravitz, A. V., Freeze, B. S., Parker, P. R. L., Kay, K., Thwin, M. T., Deisseroth, K., & Kreitzer, A. C. (2010) · Nature · doi:10.1038/nature09159 · Cited by 1,885
Ehringer, H., & Hornykiewicz, O. (1960) · Klinische Wochenschrift · doi:10.1007/bf01485901 · Cited by 1,867
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705
Pathological synchronization in Parkinson's disease: networks, models and treatments
Hammond, C., Bergman, H., & Brown, P. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.05.004 · Cited by 1,629
Parkinson, J. (2002) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.14.2.223 · Cited by 1,628
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C. R., Oueslati, A., & Masliah, E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3406 · Cited by 1,622
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R. L. A., Kim, J., May, J., Tocilescu, M. A., Liu, W., Ko, H. S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911187107 · Cited by 1,616
Self-citationBender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
The central nervous system and the gut microbiome
Sharon, G., Sampson, T. R., Geschwind, D. H., & Mazmanian, S. K. (2016) · Cell · doi:10.1016/j.cell.2016.10.027 · Cited by 1,513
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,433
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,376
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301
3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists
CARLSSON, A., LINDQVIST, M., & MAGNUSSON, T. (1957) · Nature · doi:10.1038/1801200a0 · Cited by 1,278
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203
WILSON, S. A. K. (1912) · Brain · doi:10.1093/brain/34.4.295 · Cited by 1,136
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van den Haute, C., Melki, R., & Baekelandt, V. (2015) · Nature · doi:10.1038/nature14547 · Cited by 1,130
Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease
Ibáñez, P., Bonnet, A.-M., Débarges, B., Lohmann, E., Tison, F., Agid, Y., Dürr, A., Brice, A., & Pollak, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17104-3 · Cited by 1,044
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995
Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
Shin, J.-H., Ko, H. S., Kang, H., Lee, Y., Lee, Y.-I., Pletinkova, O., Troconso, J. C., Dawson, V. L., & Dawson, T. M. (2011) · Cell · doi:10.1016/j.cell.2011.02.010 · Cited by 953
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308947200 · Cited by 913
Kraytsberg, Y., Kudryavtseva, E., McKee, A. C., Geula, C., Kowall, N. W., & Khrapko, K. (2006) · Nature Genetics · doi:10.1038/ng1778 · Cited by 887
Parkinson Disease in Twins: An Etiologic Study
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 867
A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
Hernán, M. A., Takkouche, B., Caamaño‐Isorna, F., & Gestal‐Otero, J. J. (2002) · Annals of Neurology · doi:10.1002/ana.10277 · Cited by 818
Demonstration and mapping out of nigro-neostriatal dopamine neurons
Andén, N.-E., Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.-Å., & Larsson, K. (1964) · Life Sciences · doi:10.1016/0024-3205(64)90161-4 · Cited by 813
Parkinson’s Disease and Movement Disorders
(2005) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10587 · Cited by 798
Closed-Loop Deep Brain Stimulation Is Superior in Ameliorating Parkinsonism
Rosin, B., Slovik, M., Mitelman, R., Rivlin-Etzion, M., Haber, S. N., Israel, Z., Vaadia, E., & Bergman, H. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.023 · Cited by 793
Recent Advances in the Molecular Biology of Dopamine Receptors
Gingrich, J. A., & Caron, M. G. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.001503 · Cited by 779
A common LRRK2 mutation in idiopathic Parkinson's disease
Gilks, W. P., Abou-Sleiman, P. M., Gandhi, S., Jain, S., Singleton, A., Lees, A. J., Shaw, K., Bhatia, K. P., Bonifati, V., Quinn, N. P., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17830-1 · Cited by 774
G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome
Lesage, S., Anheim, M., Letournel, F., Bousset, L., Honoré, A., Rozas, N., Pieri, L., Madiona, K., Dürr, A., Melki, R., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23894 · Cited by 711
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
Mao, X., Ou, M. T., Karuppagounder, S. S., Kam, T.-I., Yin, X., Xiong, Y., Ge, P., Umanah, G. E., Brahmachari, S., Shin, J.-H., et al. (2016) · Science · doi:10.1126/science.aah3374 · Cited by 690
THE OCCURRENCE, DISTRIBUTION AND PHYSIOLOGICAL ROLE OF CATECHOLAMINES IN THE NERVOUS SYSTEM
Carlsson, A. (1959) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07428-9 · Cited by 689
Schapira, A. H. V., Mann, V. M., Cooper, J. M., Dexter, D., Daniel, S. E., Jenner, P., Clark, J. B., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05809.x · Cited by 673
On the Presence of 3-Hydroxytyramine in Brain
CARLSSON, A., LINDQVIST, M., MAGNUSSON, T., & WALDECK, B. (1958) · Science · doi:10.1126/science.127.3296.471 · Cited by 634
Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease
de Hemptinne, C., Swann, N. C., Ostrem, J. L., Ryapolova-Webb, E. S., San Luciano, M., Galifianakis, N. B., & Starr, P. A. (2015) · Nature Neuroscience · doi:10.1038/nn.3997 · Cited by 623
Austin, S., & St-Pierre, J. (2012) · Journal of Cell Science · doi:10.1242/jcs.113662 · Cited by 608
Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews
Aharon-Peretz, J., Rosenbaum, H., & Gershoni-Baruch, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033277 · Cited by 597
Mitochondria: The Next (Neurode)Generation
Schon, E. A., & Przedborski, S. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.003 · Cited by 568
Self-citationWhy Don't We Move Faster? Parkinson's Disease, Movement Vigor, and Implicit Motivation
Mazzoni, P., Hristova, A., & Krakauer, J. W. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0264-07.2007 · Cited by 557
Luoma, P., Melberg, A., Rinne, J. O., Kaukonen, J. A., Nupponen, N. N., Chalmers, R. M., Oldfors, A., Rautakorpi, I., Peltonen, L., Majamaa, K., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16983-3 · Cited by 548
Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease
van der Walt, J. M., Nicodemus, K. K., Martin, E. R., Scott, W. K., Nance, M. A., Watts, R. L., Hubble, J. P., Haines, J. L., Koller, W. C., Lyons, K., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/373937 · Cited by 537
Basal ganglia subcircuits distinctively encode the parsing and concatenation of action sequences
Jin, X., Tecuapetla, F., & Costa, R. M. (2014) · Nature Neuroscience · doi:10.1038/nn.3632 · Cited by 498
THE BRAIN-STEM LESIONS IN PARKINSONISM
Greenfield, J. G., & Bosanquet, F. D. (1953) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.16.4.213 · Cited by 494
Shults, C. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509567103 · Cited by 476
The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies
Goetz, C. G. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008862 · Cited by 470
Advances in the genetics of Parkinson disease
Trinh, J., & Farrer, M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.132 · Cited by 466
A novel α-synuclein missense mutation in Parkinson disease
Proukakis, C., Dudzik, C. G., Brier, T., MacKay, D. S., Cooper, J. M., Millhauser, G. L., Houlden, H., & Schapira, A. H. (2013) · Neurology · doi:10.1212/wnl.0b013e31828727ba · Cited by 449
Lesage, S., Drouet, V., Majounie, E., Deramecourt, V., Jacoupy, M., Nicolas, A., Cormier-Dequaire, F., Hassoun, S. M., Pujol, C., Ciura, S., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.01.014 · Cited by 434
Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease
Banati, R. B., Daniel, S. E., & Blunt, S. B. (1998) · Movement Disorders · doi:10.1002/mds.870130205 · Cited by 431
Advances in markers of prodromal Parkinson disease
Postuma, R. B., & Berg, D. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.152 · Cited by 405
Complementary Contributions of Striatal Projection Pathways to Action Initiation and Execution
Tecuapetla, F., Jin, X., Lima, S. Q., & Costa, R. M. (2016) · Cell · doi:10.1016/j.cell.2016.06.032 · Cited by 394
A Manual of Diseases of the Nervous System
Gowers, W. R. (1888) · The American Journal of Psychology · doi:10.2307/1411377 · Cited by 371
Dopamine Is Required for the Neural Representation and Control of Movement Vigor
Panigrahi, B., Martin, K. A., Li, Y., Graves, A. R., Vollmer, A., Olson, L., Mensh, B. D., Karpova, A. Y., & Dudman, J. T. (2015) · Cell · doi:10.1016/j.cell.2015.08.014 · Cited by 361
A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions
Ivar Walaas, S., Aswad, D. W., & Greengard, P. (1983) · Nature · doi:10.1038/301069a0 · Cited by 345
The Parkinson's disease–linked proteins Fbxo7 and Parkin interact to mediate mitophagy
Burchell, V. S., Nelson, D. E., Sanchez-Martinez, A., Delgado-Camprubi, M., Ivatt, R. M., Pogson, J. H., Randle, S. J., Wray, S., Lewis, P. A., Houlden, H., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3489 · Cited by 341
INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM
POIRIER, L. J., & SOURKES, T. L. (1965) · Brain · doi:10.1093/brain/88.1.181 · Cited by 339
Opponent and bidirectional control of movement velocity in the basal ganglia
Yttri, E. A., & Dudman, J. T. (2016) · Nature · doi:10.1038/nature17639 · Cited by 338
Mirza, B., Hadberg, H., Thomsen, P., & Moos, T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00455-8 · Cited by 327
Thiruchelvam, M., Brockel, B. J., Richfield, E. K., Baggs, R. B., & Cory-Slechta, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02496-3 · Cited by 324
Age at Onset in Two Common Neurodegenerative Diseases Is Genetically Controlled
Li, Y.-J., Scott, W. K., Hedges, D. J., Zhang, F., Gaskell, P. C., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Pahwa, R., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339815 · Cited by 312
Cell-based therapies for Parkinson disease—past insights and future potential
Barker, R. A., Drouin-Ouellet, J., & Parmar, M. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.123 · Cited by 306
A Manual of Diseases of the Nervous System
Gowers, W. R. (1887) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-188702000-00011 · Cited by 295
A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration
Walsh, D. M., & Selkoe, D. J. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.13 · Cited by 294
Hökfelt, T., & Ungerstedt, U. (1973) · Brain Research · doi:10.1016/0006-8993(73)90791-9 · Cited by 292
Neural mechanisms in disorders of movement
Crossman, A. R. (1989) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(89)90201-6 · Cited by 275
Parkinson's Disease and Movement Disorders
Jankovic, J. J., & Tolosa, E. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00637.x · Cited by 264
Distribution of catechol compounds in human brain
Sano, I., Gamo, T., Kakimoto, Y., Taniguchi, K., Takesada, M., & Nishinuma, K. (1959) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(59)90652-3 · Cited by 263
Risk of Parkinson's disease among first-degree relatives: A community-based study
Marder, K., Tang, M.-X., Mejia, H., Alfaro, B., Cote, L., Louis, E., Groves, J., & Mayeux, R. (1996) · Neurology · doi:10.1212/wnl.47.1.155 · Cited by 248
Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa
Smith, Y., Wichmann, T., Factor, S. A., & DeLong, M. R. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.212 · Cited by 240
Further evidence for the presence of nigro‐neostriatal dopamine neurons in the rat
Andén, N., Dahlström, A., Fuxe, K., & Larsson, K. (1965) · American Journal of Anatomy · doi:10.1002/aja.1001160117 · Cited by 236
Chapter 36: Astrocytes and Parkinson's disease
Forno, L. S., DeLanney, L. E., Irwin, I., Monte, D. D., & Langston, J. W. (1992) · Progress in Brain Research · doi:10.1016/s0079-6123(08)61770-7 · Cited by 230
Compston, A. (2009) · Brain · doi:10.1093/brain/awp193 · Cited by 220
Catechol Compounds in Rat Tissues and in Brains of Different Animals
MONTAGU, K. A. (1957) · Nature · doi:10.1038/180244a0 · Cited by 206
Nigral and extranigral pathology in Parkinson's disease.
Braak, H., Braak, E., Yilmazer‐Hanke, D., Schultz, C., de Vos, R. A. I., & Jansen, E. N. H. (1995) · PubMed · Cited by 198
Association of Single-Nucleotide Polymorphisms of the Tau Gene With Late-Onset Parkinson Disease
Martin, E. R. (2001) · JAMA · doi:10.1001/jama.286.18.2245 · Cited by 191
Using genome-wide complex trait analysis to quantify ‘missing heritability’ in Parkinson’s disease
Keller, M. F., Saad, M., Bras, J., Bettella, F., Nicolaou, N., Simon-Sanchez, J., Mittag, F., Buchel, F., Sharma, M., Gibbs, J. R., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds335 · Cited by 190
Encephalitis Lethargica, Its Sequelae and Treatment.
(1932) · Journal of the American Medical Association · doi:10.1001/jama.1932.02730290071039 · Cited by 178
The medical treatment of Parkinson disease from James Parkinson to George Cotzias
Fahn, S. (2015) · Movement Disorders · doi:10.1002/mds.26102 · Cited by 162
Drug Insight: continuous dopaminergic stimulation in the treatment of Parkinson's disease
Olanow, C., Obeso, J., & Stocchi, F. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0222 · Cited by 150
Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family
Swerdlow, R. H., Parks, J. K., Davis, J. N., Cassarino, D. S., Trimmer, P. A., Currie, L. J., Dougherty, J., Bridges, W. S., Bennett, J. P., Wooten, G. F., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440605 · Cited by 148
Neuromelanin and Parkinson's disease.
MARSDEN, C. D. (1983) · PubMed · Cited by 144
Valera, E., Spencer, B. J., & Masliah, E. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0397-z · Cited by 141
Zur pathologischen Anatomie der Paralysis agitans
Fünfgeld, E. W. (1923) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02869021 · Cited by 135
Parkin and Parkinsonʼs disease
Mizuno, Y., Hattori, N., Mori, H., Suzuki, T., & Tanaka, K. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00008 · Cited by 126
Postencephalitic parkinsonism – a review
Casals, J., Elizan, T. S., & Yahr, M. D. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050086 · Cited by 108
Maternal inheritance in Parkinson's disease
Wooten, G. F., Currie, L. J., Bennett, J. P., Harrison, M. B., Trugman, J. M., & Parker, W. D. (1997) · Annals of Neurology · doi:10.1002/ana.410410218 · Cited by 93
Functional Neuroimaging in Parkinson's DiseasePreprint
Niethammer, M., Feigin, A., & Eidelberg, D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009274 · Cited by 90
Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease
Kösel, S., Grasbon-Frodl, E. M., Mautsch, U., Egensperger, R., Eitzen, U. V., Frishman, D., Hofmann, S., Gerbitz, K.-D., Mehraein, P., & Graeber, M. B. (1998) · Neurogenetics · doi:10.1007/s100480050029 · Cited by 86
RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis
Heman-Ackah, S. M., Hallegger, M., Rao, M. S., & Wood, M. J. A. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00040 · Cited by 85
Wood, A. R., Perry, J. R. B., Tanaka, T., Hernandez, D. G., Zheng, H.-F., Melzer, D. R., Gibbs, J. R., Nalls, M. A., Weedon, M. N., Spector, T. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064343 · Cited by 81
Muñoz, E., Oliva, R., Obach, V., Martı́, M. J., Pástor, P., Ballesta, F., & TOLOSA, E. S. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00710-6 · Cited by 70
Age at onset of Parkinson disease and apolipoprotein E genotypes
Zareparsi, S., Camicioli, R. M., Sexton, G. J., Bird, T. D., Swanson, P. D., Kaye, J. A., Nutt, J. G., & Payami, H. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.10111 · Cited by 66
The effects of ventromedial tegmental lesions on the biosynthesis of catecholamines in the striatum
Goldstein, M., ANAGNOSTE, B., Owen, W. S., et al. (1966) · Life Sciences · doi:10.1016/0024-3205(66)90078-6 · Cited by 56
Sur un cas de tremblement parkinsonien hémiplégique symptomatique d'une tumeur du pédoncule cérébral
BLOCQ, P., & Marinesco, G. (1893) · Medical Entomology and Zoology · Cited by 55
Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson’s disease
Nishioka, K., Vilariño‐Güell, C., Cobb, S. A., Kachergus, J. M., Ross, O. A., Hentati, E., Hentati, F., & Farrer, M. J. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.09.007 · Cited by 47
Mink, J. W. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385870-2.00030-5 · Cited by 19
(2000) · doi:10.1002/1531-8249(200011)48:5<730::aid-ana6>3.0.co;2-0
Cited by
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480
Hallmarks of neurodegenerative diseases
Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789
13 reasons why the brain is susceptible to oxidative stress
Cobley, J. N., Fiorello, M. L., & Bailey, D. M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.008 · Cited by 1,215
Inflammasomes in neuroinflammatory and neurodegenerative diseases
Voet, S., Srinivasan, S., Lamkanfi, M., & van Loo, G. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201810248 · Cited by 761
Neuroprotective Effect of Antioxidants in the Brain
Lee, K. H., Cha, M., & Lee, B. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197152 · Cited by 502
Metadata
- Authors
- Przedborski, S.
- Venue
- Nature Reviews Neuroscience
- Published
- 2017-03-17
- Volume
- 18
- Issue
- 4
- Pages
- 251-259
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2595455544
- Cited by
- 345
- References
- 130
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.